ClassID:

169275

G01N33/57473 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA

Recent Application in this class:
#1
20250389722
2025-12-25

HYBRID METAL NANOPARTICLES FOR ULTRAFAST DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA

#2
20250354991
2025-11-20

KIT FOR DETECTING GLYCOPROTEIN

#3
20250273344
2025-08-28

METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER

#4
20250230236
2025-07-17

ANTI-CEACAM6 ANTIBODIES AND METHODS OF USE

#5
20250199000
2025-06-19

CEACAM1 BASED POINT-OF-CARE CANCER DIAGNOSTIC

#6
20250012804
2025-01-09

USE OF MICROVESICLES FOR BENIGN COLORECTAL POLYPS AND COLORECTAL CANCER SCREENING

#7
20240254221
2024-08-01

Anti-CEACAM6 antibodies and methods of use

#8
20240077487
2024-03-07

METHOD FOR THE DETECTION OF LUNG CANCER

#9
20230194533
2023-06-22

Antibodies against carcinoembryonic antigens

#10
20230115540
2023-04-13

TUMOR TARGETED FLUORESCENCE GUIDANCE FOR INTRAOPERATIVE MARGIN ASSESSMENT

#11
20220340682
2022-10-27

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

#12
20220242968
2022-08-04

Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof

#13
20220213189
2022-07-07

Anti-CEACAM6 antibodies and methods of use

#14
20210371516
2021-12-02

Antibody constructs and methods of treating cancer

#15
20200393459
2020-12-17

CEACAM1 based point-of-care cancer diagnostic

#16
20200249236
2020-08-06

METHODS FOR MEASURING CARCINOEMBRYONIC ANTIGEN

#17
20200102401
2020-04-02

Anti-CEACAM5 antibodies and uses thereof

#18
20190346447
2019-11-14

Ultra-high sensitivity dual-gated biosensor based on MOS transistor

#19
20190233514
2019-08-01

Anti-CEACAM6 antibodies and methods of use

#20
20180022817
2018-01-25

Anti-CEACAM5 antibodies and uses thereof

#21
20180016338
2018-01-18

ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME

#22
20170199182
2017-07-13

QUANTITIVE ANALYTE ASSAY DEVICE AND METHOD

#23
20170108501
2017-04-20

Method for detecting a solid tumor cancer

#24
20170089907
2017-03-30

Methods for measuring carcinoembryonic antigen

#25
20160108131
2016-04-21

Anti-CEACAM5 antibodies and uses thereof

#26
20160033496
2016-02-04

Analyte detection enhancement by targeted immobilization, surface amplification, and pixelated reading and analysis

#27
20140287962
2014-09-25

Motor protein device

#28
20140213467
2014-07-31

Mucin 5B as a Pancreatic Cyst Fluid Specific Biomarker for Accurate Diagnosis of Mucinous Cysts and Other Markers Useful for Detection of Pancreatic Malignancy

#29
20140154698
2014-06-05

Methods for measuring carcinoembryonic antigen

#30
20140120554
2014-05-01

Anti CEACAM1 antibodies and methods of using same

#31
20130272958
2013-10-17

Anti-CEACAM6 antibodies and uses thereof

#32
20130035249
2013-02-07

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING CEA-EXPRESSING CANCERS

#33
20120100560
2012-04-26

DEVICE FOR CAPTURE, ENUMERATION, AND PROFILING OF CIRCULATING TUMOR CELLS

#34
20120100158
2012-04-26

Anti CEACAM1 antibodies and methods of using same

#35
20120039885
2012-02-16

COMPOSITION AND METHOD FOR CANCER TREATMENT

#36
20120028245
2012-02-02

Quantitative analyte assay device and method

#37
20110301056
2011-12-08

NECTIN-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS

#38
20110165577
2011-07-07

SELECTION OF COLORECTAL CANCER PATIENTS FOR NEO-ADJUVANT AND ADJUVENT SYSTEMIC ANTI-CANCER TREATMENT

#39
20100247438
2010-09-30

IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES

#40
20100240081
2010-09-23

Method for providing diagnosis of cancer using seprase as a marker

#41
20100173320
2010-07-08

Methods for Detecting Nucleic Acids Indicative of Cancer

#42
20100086920
2010-04-08

METHOD TO ASSESS CANCER SUSCEPTIBILITY AND DIFFERENTIAL DIAGNOSIS OF METASTASES OF UNKNOWN PRIMARY TUMORS

#43
20090291436
2009-11-26

METHODS FOR DETECTING NUCLEIC ACIDS INDICATIVE OF CANCER

#44
20090215091
2009-08-27

Diagnostic panel of cancer antibodies and methods for use

#45
20090181403
2009-07-16

CEACAM1 based point-of-care cancer diagnostic

#46
20070117123
2007-05-24

SALIVARY PROTEIN AND RNA FOR BREAST CANCER DETECTION

#47
20060141543
2006-06-29

Cellular retinoic acid binding protein II as a marker for breast cancer

#48
20060088521
2006-04-27

Composition and method for cancer treatment

#49
20060024314
2006-02-02

Antibodies and cyclic peptides which bind CEA (carcinoembryonic antigens) and their use as cancer therapeutics

#50
20060019321
2006-01-26

Planar optical waveguide based sandwich assay sensors and processes for the detection of biological targets including early detection of cancers

#51
20050272102
2005-12-08

Method for diagnosis of prostate cancer

#52
20050260638
2005-11-24

Methods for detecting nucleic acids indicative of cancer

#53
20050182568
2005-08-18

Method for evaluating a patients biological condition

#54
20050153382
2005-07-14

Biochip kit comprising biochip based on antigen-antibody reactions, and its usage